Breast Cancer

New Push For Changes In BRCA Testing

Consensus forms among cancer researchers that all Ashkenazi Jews need screening, regardless of family history.

08/02/2016 - 13:33
Deputy Managing Editor

Over the past few years, dozens of breast cancer researchers in separate labs all came to the conclusion that doctors are using the wrong criteria to decide who should be tested for the cancer-causing BRCA genes. Now they’ve banded together to convince medical professionals, insurance companies and the rest of the healthcare field to change the rules on who is, and isn’t, eligible for genetic testing.

Dr. Larry Norton: “If you only test people with family history, you’re going to miss half the cases.” COURTESY OF MSKCC

Inside The New Breast Cancer Stats

What’s an Ashkenazi woman to do?

10/27/2015 - 20:00

It’s been a busy few weeks for breast cancer. Of course, breast cancer is always busy, exerting its sneaky destruction through abnormal cell growth. But now it’s October and Breast Cancer Awareness Month, and the scary fact is everywhere again: One in eight women will be diagnosed with breast cancer during her lifetime.

The North Portico of the White House is illuminated pink earlier this month in honor of Breast Cancer Awareness Month.

Breaking The Mold On Breast Cancer

An interview with noted Hadassah oncologist Dr. Tamar Peretz on genetic testing, mammograms and why the one-size-fits-all protocol no longer makes sense.

Deputy Managing Editor
10/27/2015 - 20:00

Dr. Tamar Peretz is the director of Hadassah’s Sharett Institute of Oncology in Jerusalem and interim director general of the Hadassah Medical Organization in Jerusalem; at Hadassah, she leads the team whose genetic research and clinical studies have led to groundbreaking discoveries on BRCA1 gene mutations in the Ashkenazi community and new prevention, diagnosis and treatment approaches.

Dr. Tamar Peretz, left, with Fran Drescher at the Cancer Schmancer Women’s Health Summit in New York. Courtesy of Hadassah

Rochelle Shoretz Is Dead At 42

The activist and lawyer beat cancer in her twenties to found Sharsheret, the cancer information and support organization.

05/31/2015 - 20:00

Rochelle Shoretz, whose own breast cancer diagnosis at age 28 led her to found the national cancer organization Sharsheret, died Sunday afternoon at her home in Teaneck, New Jersey. She was 42. The cause of death was complications from breast cancer.  

Rochelle Shoretz was the founder and executive director of Sharsheret. JTA

New Subsidy For Breast Cancer Testing

Einstein-affiliated Jewish genetic health program joins with Montefiore on BRCA1/2 screening.

Managing Editor
01/20/2015 - 19:00

Beginning this week, the Program for Jewish Genetic Health, a nonprofit affiliated with Yeshiva University and the school’s Albert Einstein College of Medicine, is teaming up with Montefiore Health System to offer subsidized genetic testing for Ashkenazi women and men who might be carriers of the BRCA1/2 genes for breast cancer. The cost for the test is $100. To discuss the test and broader questions about breast cancer, The Jewish Week spoke with Dr. Susan Klugman, medical director for the Program for Jewish Genetic Health, director of the division of reproductive genetics at Montefiore, and professor of clinical obstetrics and gynecology and women’s health at Einstein. The interview was conducted via email.

Dr. Susan Klugman

A More Definitive Breast Cancer Test?

Diagnostic screening tool that looks at immune system has its R&D center in Jerusalem.

Israel Correspondent
10/21/2014 - 20:00

Jerusalem —Tamar, an Israeli woman in her early 50s, is at high risk for breast cancer, but the very dense tissue in her breasts prevents the most widely used tests — mammograms and ultrasounds — from offering a definitive “all-clear.” 

Octava Pink measures cancer-specific auto-antibodies. Courtesy of Eventus Diagnostics

Study: Test All Women Of Ashkenazi Descent For BRCA Defect

09/07/2014 - 20:00

Jerusalem — All women of Ashkenazi descent should be screened from age 30 for the BRCA gene mutation that causes breast cancer, an Israeli study recommends.

The Big BRCA Questions

Panel moderated by Barbara Walters discusses the benefits and perils of early detection of breast and ovarian cancer.
10/15/2013 - 20:00
Jewish Week Correspondent

If you were at a higher risk for cancer, would you want to know about it? How early? And what preventative measures would be worth the financial cost and emotional strain?

‘There Were Still Choices I Could Make’

Alice Hoffman’s breast cancer memoir is really a guide for going through difficult times.
10/15/2013 - 20:00
Jewish Week Book Critic

Being a caregiver came much more naturally to Alice Hoffman than being cared for. For decades, the bestselling novelist was the one who took friends and relatives to the doctor, sat at bedsides, thoroughly researched diseases and arranged for cemetery plots and funerals. Fifteen years ago, when she found a lump on her breast, she was certain that she only imagined it, as things like that didn’t happen to her, and she didn’t have time to be ill. But a call from her doctor, “Alice, I’m sorry,” brought the stark truth.

"I could not run away from my circumstances, or control the path of my disease," Hoffman says. Photo courtesy Algonquin

Angelina’s `Jewish Gene’

The actress wrote a new NYT oped about her prophylactic surgery; here's the JW's take on all the talk.

05/18/2013 - 20:00
Special To The Jewish Week

Celebrity Angelina Jolie's recent decision to opt for prophylactic surgery after she determined she is a carrier of a mutation in the BRCA1 gene has prompted media attention the world over. Media descriptions of her “Jewish gene”, however, are misguided. 

As Angelina Jolie has found, you don't have to be of Jewish descent to carry the BRCA1 or BRCA2 genes.
Syndicate content